project id: TCGA-THCA; case submitter id: TCGA-4C-A93U; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.01; rna integrity number: 7.2; age at index: 74; days to birth: -27348; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1939; age at diagnosis: 27348; ajcc pathologic m: M0; ajcc pathologic n: N1b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 129.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 75; days to sample procurement: 0; initial weight: 800.0; portion submitter id: TCGA-4C-A93U-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 65.0;